[go: up one dir, main page]

SE9301324D0 - New method of treatment - Google Patents

New method of treatment

Info

Publication number
SE9301324D0
SE9301324D0 SE19939301324A SE9301324A SE9301324D0 SE 9301324 D0 SE9301324 D0 SE 9301324D0 SE 19939301324 A SE19939301324 A SE 19939301324A SE 9301324 A SE9301324 A SE 9301324A SE 9301324 D0 SE9301324 D0 SE 9301324D0
Authority
SE
Sweden
Prior art keywords
treatment
new method
bacteraemia
adenosine
activation
Prior art date
Application number
SE19939301324A
Other languages
English (en)
Inventor
*Sollevi Alf
Original Assignee
Item Development Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Item Development Ab filed Critical Item Development Ab
Priority to SE19939301324A priority Critical patent/SE9301324D0/sv
Publication of SE9301324D0 publication Critical patent/SE9301324D0/sv
Priority to US08/144,803 priority patent/US5648341A/en
Priority to CA002160689A priority patent/CA2160689C/en
Priority to PCT/SE1994/000001 priority patent/WO1994004017A2/en
Priority to JP6506175A priority patent/JPH08508710A/ja
Priority to AT94903224T priority patent/ATE185484T1/de
Priority to AU57246/94A priority patent/AU5724694A/en
Priority to EP94903224A priority patent/EP0695185B1/en
Priority to DE69421174T priority patent/DE69421174T2/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
SE19939301324A 1993-04-21 1993-04-21 New method of treatment SE9301324D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE19939301324A SE9301324D0 (sv) 1993-04-21 1993-04-21 New method of treatment
US08/144,803 US5648341A (en) 1993-04-21 1993-10-28 Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution
CA002160689A CA2160689C (en) 1993-04-21 1994-01-03 New method of treatment
PCT/SE1994/000001 WO1994004017A2 (en) 1993-04-21 1994-01-03 New method of treatment
JP6506175A JPH08508710A (ja) 1993-04-21 1994-01-03 新規処置方法
AT94903224T ATE185484T1 (de) 1993-04-21 1994-01-03 Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge
AU57246/94A AU5724694A (en) 1993-04-21 1994-01-03 New method of treatment
EP94903224A EP0695185B1 (en) 1993-04-21 1994-01-03 Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions
DE69421174T DE69421174T2 (de) 1993-04-21 1994-01-03 Verwendung von adenosin zur herstellung eines arzneimittels zur behandlung entzüdlicher reaktionen der lunge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301324A SE9301324D0 (sv) 1993-04-21 1993-04-21 New method of treatment

Publications (1)

Publication Number Publication Date
SE9301324D0 true SE9301324D0 (sv) 1993-04-21

Family

ID=20389651

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301324A SE9301324D0 (sv) 1993-04-21 1993-04-21 New method of treatment

Country Status (9)

Country Link
US (1) US5648341A (sv)
EP (1) EP0695185B1 (sv)
JP (1) JPH08508710A (sv)
AT (1) ATE185484T1 (sv)
AU (1) AU5724694A (sv)
CA (1) CA2160689C (sv)
DE (1) DE69421174T2 (sv)
SE (1) SE9301324D0 (sv)
WO (1) WO1994004017A2 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
US5998386A (en) 1997-09-19 1999-12-07 Feldman; Arthur M. Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue
WO2007112986A1 (en) * 2006-03-31 2007-10-11 Adenobio N.V. Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231086A (en) * 1985-09-24 1993-07-27 Item Development Aktiebolag Continuous administration adenosine to increase myocardial blood flow
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance

Also Published As

Publication number Publication date
WO1994004017A2 (en) 1994-03-03
DE69421174D1 (de) 1999-11-18
ATE185484T1 (de) 1999-10-15
CA2160689A1 (en) 1994-03-03
EP0695185B1 (en) 1999-10-13
JPH08508710A (ja) 1996-09-17
CA2160689C (en) 1999-11-02
AU5724694A (en) 1994-03-15
DE69421174T2 (de) 2000-02-10
WO1994004017A3 (en) 1994-09-01
EP0695185A1 (en) 1996-02-07
US5648341A (en) 1997-07-15

Similar Documents

Publication Publication Date Title
AU5947396A (en) Dimer of molecular variant of apolipoprotein and processes for the production thereof
RU93054168A (ru) Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
ATE218164T1 (de) Hemmung der fortpflanzung von arterienglattmuskelzellen
CA2157925A1 (en) Treatment of Mycobacterial Diseases by Administration of Bactericidal/Permeability-Increasing Protein Products
DE69024104D1 (de) Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase
EP0372670A3 (en) Hirudin peptides for inhibiting platelet aggregation
RU92016490A (ru) Новые 2-сахаринилметил(арил и арокси)ацетаты, применимые в качестве ингибиторов протеолитических ферментов, их композиции и способ их применения
GR3036691T3 (en) Dna sequences related to isolated fragile x syndrome
GR3004988T3 (sv)
SE9301324D0 (sv) New method of treatment
WO1990013281A3 (en) Method of suppressing hiv infection
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
JPS6456699A (en) Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
FR2409996A1 (fr) 15-epi-prostacycline et analogues, utiles notamment comme agents antithrombotiques et thrombolytiques et leur procede de preparation
DK360388D0 (da) Laegemiddel til behandling af hjerteinsufficiens
CA2157856A1 (en) Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
IT8720288A0 (it) Forno per il trattamento di articoli di pelletteria o simili,quali le calzature, applicabile a catene continue di lavorazione.
DK0688786T3 (da) Hydrazino- og hydroxyamino-14beta-hydroxyandrostanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse.
IT1285056B1 (it) Corredo di infusione, particolarmente per la somministrazione parenterale di acido tioctico.
FR2433021A1 (fr) Oligomeres de pyridocarbazoles et leur application therapeutique
IT8746819A0 (it) Barra a doppia funzione per il trattamento di colture al coperto, come le coltivazioni in serra
UA6981A (uk) Спосіб проведення гемосорбції